Enquanto que o trabalho de Haraway esta repleto de figuras inspiradoras como o ciborgue, o primata, o coiote trapaceiro, o
OncoMouse e o canino, todos reconceituando a agencia em termos mais-que-humanos, o trabalho de Barad apresenta uma reconceituacao mais abstrata da agencia material advinda da fisica.
Case in point was the difficulties in cancer research being encountered due to the so-called "DuPont
Oncomouse Patents" originating from Harvard University.
This avoids the Harvard
oncomouse situation, described in Part V.
The
Oncomouse that Roared: Hybrid Exchange Strategies as a Source of Distinction at the Boundary of Overlapping Institutions.
In the West, humans have long been defined in opposition to animals, but these categories have been effaced, Haraway observes, through the figure of the
oncomouse (a transgenic mouse in which a human oncogene was transplanted).
There have been " rivalries for power and information," which find expression in the burying of competing theories and therapies, the ignoring of disfavored hypotheses, sharp competition treating research as a race between contenders, and a desire for exclusivity such as when the
OncoMouse in 1988 became "the first animal patented in history.
Fiona Murray, The
Oncomouse that Roared: Hybrid Exchange Strategies as a Source of Distinction at the Boundary of Overlapping Institutions, 116 AM.
It is here that a different interaction between the human and the animal occurs in which the boundaries are blurred in distinctly problematic ways that have been explored by Donna Haraway, for example, in her portrayal of
Oncomouse.
her coauthors have shown in connection with the
oncomouse, which is used
En 1987 las patentes se extendieron a los animales que procedian de los laboratorios y, asi, un ano mas tarde la universidad de Harvard patentaba el
oncomouse, un raton transgenico modificado mediante el anadido de un gen capaz de hacerlo mas susceptible al desarrollo de tumores.
In her critical work on the patented
OncoMouse for cancer research, Donna Haraway reads patent law as a hybrid network.
This is in direct contrast to the United States, where a patent was granted on the
oncomouse in 1988.
